4SC Further Strengthens Patent Protection for its Lead Compound Resminostat
News Oct 21, 2014
4SC AG has announced that the company has further strengthened the patent protection for its lead anti-cancer compound resminostat.
The US Patent Office has granted the patent for resminostat's manufacturing process. The patent, which runs until 20 July 2029, protects the chemical process used in the manufacture of resminostat. This constitutes an additional obstacle for potential competitors while further extending the total term of resminostat's portfolio of property rights.
Overall, this means the resminostat manufacturing process is protected until 2029 in almost all key markets around the world, including Europe, Japan, China, Russia, Hong Kong, Singapore and Australia - and now the USA.
This supplements worldwide protection for resminostat's strategically important composition-of-matter patent, which was achieved on a global basis already in 2013.
Enno Spillner, Chief Executive Officer of 4SC, said: "We are pleased to announce the protection of the resminostat manufacturing method in the world's most important markets, in addition to its material composition. This contributes another strategically important element to our lead compound's patent portfolio. We believe it is important to take action sufficiently early to prepare resminostat for a subsequent global marketing strategy."
Neuroblastoma Biomarker Research Advances TreatmentNews
Neuroblastoma, a childhood cancer, is treatable in less than half of aggressive cases, but new RNA biomarkers may help identify high-risk patients faster and lead to better prognosis.READ MORE
Cancer Comes Back All 'Jacked Up' on Stem CellsNews
Recent work increasingly shows that tumors are not static - the populations of cells that make up a tumor evolve over time in response to treatment, often in ways that lead to treatment immunity. Instead of being defined by a snapshot, tumors are more like a movie. This means that a tumor that recurs after treatment may be much different than the tumor originally seen in a biopsy.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018